Introduction {#Sec1}
============

Computed tomography (CT) is valuable diagnostic tool widely used in medical practices. Unfortunately, this technique employs use of X-ray radiation resulting in relatively high average effective doses from 2.4 mSv (head examination) up to12.4 mSv (abdomen), usually exceeding the average yearly doses from natural radiation of 2.4 mSv \[[@CR1]\]. Because of the powerful diagnostic possibilities with CT and its clinical benefits, the use of CT has increased explosively. For example, in the UK the use of CT has grown in the last decade from accounting for 5--11 % of all X-ray examinations to contributing up to 68 % of the collective radiation doses from these sources \[[@CR2]\]. According to the 2008 UNSCEAR report, 221 million CT examinations are performed annually worldwide \[[@CR1]\] with over 70 million in US alone in 2007 \[[@CR4]\]. Moreover, a rapid increase in paediatric CT has been observed, and because children experience higher lifetime risks of fatal cancer with each dose, one can expect an increased incidence in some types of cancers attributable to CT among this group. Despite many reports concerning the estimated cancer risk from CT \[[@CR3], [@CR4]\], particularly from paediatric CT \[[@CR5]\], the problem of the dose reduction during CT scans has frequently been underestimated \[[@CR6]\]. This problem has been additionally exacerbated by questioning the validity of the linear, no-threshold model (LNT) for the relationship between an effective dose and increased cancer risks for doses below 100 mSv \[[@CR7], [@CR8]\]. However, recent statistically based epidemiological studies have proven a long-term link between early childhood exposure for treatment of an enlarged thymus (low-dose chest therapy) with an increase in the relative risk of thyroid cancers in patients as compared with their non-irradiated siblings \[[@CR9]\]. Similarly, a recent report concerning a large study of over 176,000 patients examined using CT in the National Health Service centres in the UK demonstrated a positive association between the radiation dose from CT scans and leukaemia and brain tumours \[[@CR10]\]. These findings confirmed the necessity of developing new guidelines for CT scans to reduce the doses of radiation received during these examinations.

Designing new CT machines with reduced radiation exposure with improvement in the CT techniques could offer the ability to scan a chosen portion of the patient using low-tube voltage protocols to substantially decrease the doses \[[@CR11]\].

An alternative method for dose reduction during CT examination involves the use of plastic composites with metal additives as a shield, particularly for radiosensitive organs such as the eyes, thyroid glands, breast or gonads. Such planar shields containing bismuth compounds are currently used in radiology as they are commercially available, and their practical use has recently been reviewed \[[@CR6]\]. However, the use of these shields is recommended on the basis of dose reduction determined at positions chosen using human-tissue-equivalent anthropomorphic phantoms \[[@CR12], [@CR13]\]. Application of heavy metal additives is crucial due to their strong X-ray radiation attenuation capabilities. However, one must keep in mind that excitation of heavy metal atoms after absorption of the incoming X-ray radiation may result in the generation of secondary X-ray fluorescence radiation, which can escape the shields and diminish their absorption effect. This effect can cause the artifactually increase CT of numbers and adversely affect the accuracy of CT numbers as well as may also influence the image quality of the CT scan \[[@CR14]\]. The other disadvantages, associated with the use of bismuth shields, especially when used with automatic exposure control or tube current modulation. may lead to unpredictable and potentially undesirable levels of dose. Therefore, AAPM \[[@CR15]\] and the Society of Cardiac CT stated, that these shields are not recommended for CT scanning \[[@CR16]\]. However, such attitude is also discussed, as the use of bismuth shields has unquestionable advantages, especially in paediatric CT and some of these disadvantages can be simply reduced \[[@CR17], [@CR18]\].

A simple way to improve the quality of CT scans with simultaneous reducing of the doses with bismuth shield is reducing of the dispersed by these shields radiation.

The principal idea of this study was to evaluate the contribution of secondary excited X-ray fluorescence in Bi-containing shields and to examine the possibility of reducing its intensity via the simultaneous application of a few metal additives to absorb X-ray photons of sequentially higher excitation energies and shift them to lower energy bands that are much easier to attenuate and do not impact either the total dose absorbed during or the diagnostic quality of the CT scans.

Materials and methods {#Sec2}
=====================

Eight different elastomeric shields containing Bi, W, Gd and Sb in various proportions have been prepared to determine the dose reduction factor (DRF) and their suitability as shields in CT examination procedures.

The elastomeric samples have been prepared by pressing natural rubber with typical vulcanisation additives and with heavy metal admixtures in the form of the following oxides: Bi~2~O~3~, WO~3~, Gd~2~O~3~ and Sb~2~O~3~. The final vulcanisation has been carried out at 160 °C. The rubber compounds with their formulations are provided in Table [1](#Tab1){ref-type="table"}.Table 1Composition of elastomer mixturesSample codeNR (g)ZnO (phr)Sulphur (phr)MBT (phr)Stearic acid (phr)Bi (Bi~2~O~3~) (phr)W (WO~3~) (phr)Gd (Gd~2~O~3~) (phr)Sb (Sb~2~O~3~) (phr)M11005221100 (111.5)------M21005221100 (111.5)50 (63)----M31005221100 (111.5)50 (63)25 (28.8)--M41005221100 (111.5)50 (63)25 (28.8)10 (12)G1100522150 (55.75)------G2100522150 (55.75)50 (63)----G3100522150 (55.75)50 (63)50 (57.6)--G4100522150 (55.75)50 (63)50 (57.6)50 (60)*phr* parts per hundred rubber, *nr* natural rubber, *MBT 2*-Mercaptobenzothiazole

Using this procedure, radiopaque composite elastomers in the form of planar shields (25 × 25 cm^2^) with a thickness of 1 mm were obtained as a starting material for the protective shields \[[@CR19]\]. The lead equivalent of these natural rubber vulcanisates was 0.04--0.16 mm at 60 keV X-ray radiation. The detailed compositions of the examined shields are presented in Table [2](#Tab2){ref-type="table"}, with samples of equal metallic additive content (G1--G4) and with heavy metal content that decreases progressively in the following order: Bi, W, Gd and Sb (samples M1--M4). To study new compositions, two commercially available shields have been examined (SOMATEX^®^ CT Shields, samples EP and Z, SOMATEX MEDICAL TECHNOLOGIES GMBH, Germany).Table 2Elemental composition of the examined shieldsSample codeThickness (cm)Thickness (g/cm^2^)Density (g/cm^3^)Mass fractionHCNOSZnSbGdWBiM10.1160.1951.6850.05430.40600.00080.05680.01250.01810.4515M20.1200.2442.0320.04230.31610.00060.09000.00970.01410.17560.3515M30.1050.2302.1900.03840.28710.00050.09390.00880.01280.07980.15950.3192M40.1080.2362.1850.03700.27650.00050.09650.00850.01230.03080.07680.15360.3075G10.0980.1341.3630.07250.54260.00100.04120.01670.02420.3017G21.0000.1780.1780.05250.39310.00070.08690.01210.01760.21850.2185G30.0930.1761.8940.04200.31400.00060.09610.00970.01400.17460.17460.1746G40.0950.1741.8360.03470.25970.00050.10790.00800.01160.14440.14440.14440.1444EP0.0430.1623.789nanananananana+++Z0.1030.1721.668nanananananana----+"+" or "−" presence detected or not detected*na* data not available

For a radiation source that mimics the X-ray tube radiation used in CT, a Co-57 closed isotopic source has been applied providing γ-rays of 122.1 (85.6 %) and 136.5 (10.7 %) keV., which closely approximates the typical X-ray tube voltages applied in CT examinations. The intensity of the excited X-ray photons was measured using a γ-ray spectrometry system with a high-resolution REGe detector placed in a 5 cm thick lead shielding housing lined with a 5 mm thick Zn plate cylinder. The resolution of the detector was 0.9 keV for the 122 keV peak, and its relative efficiency was 20 % for the 1.33 MeV peak. The data were processed using a model S404 Inspector Spectroscopy System (Canberra). Details of the detection system are described elsewhere \[[@CR20]\]. A schematic diagram of the measuring system is shown in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Schematic diagram of the experimental setup

The Co-57 radionuclide was commercially available and sealed in a polycarbonate case. To minimize the excitation of the atoms from the lead shield and the possible interference of their radiation with the detector, the Co-57 source was also placed in a brass shielding housing. Two brass collimators were used to diminish the influence of scattered radiation. All spectra were recorded using Genie 2000 software from Canberra over 1,800 s. Each elastomeric shield sample had dimensions of approximately 4 × 4 cm^2^. The active area of the sample, visible to the detector, was a 12.3 mm diameter surface (\~120 mm^2^). The mass attenuation coefficients for the two main Co-57 emission lines (122.1 and 136.5 keV) were determined according to the well-known exponential dependence:$$\documentclass[12pt]{minimal}
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                \begin{document}$$ I = I_{\text{o}} e^{ - \mu x} $$\end{document}$$in which *μ* is the mass attenuation coefficient in cm^2^/g and *x* is the thickness in g/cm^2^. The given formula meets all experimental conditions for a narrow monoenergetic photon beam; otherwise, a build-up factor (B) should be introduced. In our experiments no build-up factor was required for Eq. [1](#Equ1){ref-type=""}, as confirmed during the validation experiments.

Because many naturally occurring radionuclides contribute to the background radiation in the γ- and X-ray spectra within the energy range of interest (from 40 to 100 keV measured over 60,000 s), their contribution to the natural detector background was subtracted from each recorded spectrum. In addition, to achieve better accuracy and more reliable results, a correction for the Compton continuum was performed.

Calculations of the theoretical mass attenuation coefficients based on the sample compositions were performed using XCom software available from the National Institute of Standards and Technology (NIST) website \[[@CR21], [@CR22]\]. The composition data for the human tissue (soft) used (H 10.20 %, C 14.30 %, N 3.40 %, O 70.80 %, Na 0.20 %, P 0.30 %, S 0.30 %, Cl 0.20 %, K 0.30 %) to calculate the mass attenuation coefficient and dose reduction factor were also taken from the NIST database \[[@CR23]\] and based on the data included in the ICRU 44 report \[[@CR24]\].

Results and discussion {#Sec3}
======================

The experimental procedure required validation of the experimental setup and methods used for the calculations. Simple measurements of the standardised Pb plates were carried out for this validation during which the mass attenuation coefficients were determined for the lead. The results obtained were in good agreement with the theoretical values, and the relative error of this method was approximately 1 %. These values confirm that this methodology can be successfully applied for mass attenuation coefficient measurements in samples of novel composition whose physical properties have not been fully determined. The application of a Co-57 radiation source only allows for experimental determination of mass attenuations coefficients for 122.1 and 136.5 keV photons. The measured values of the attenuation coefficients for the Co-57 γ lines at 122.1 and 136.5 keV are in good agreement with the values calculated taking into account the elastomer compositions. The relative deviation between the measured values and those calculated does not exceed 15 %. The lower energy mass attenuation coefficients used to calculate the dose reduction factor were determined via calculations based on a particular sample composition. Table [3](#Tab3){ref-type="table"} presents the calculated and measured values for the *μ* coefficients and the equivalent lead values for the investigated shields at both 122.1 and 136.5 keV.Table 3Attenuation coefficients for 122.1 and 136.5 keV photons and calculated lead equivalents values for investigated elastomeric compositesElastomer*d* (1 layer) (g/cm^2^)*μ* ~122.1~ (cm^2^/g)*R* ~Pb-122.1~ (mm)*μ* ~136.5~ (cm^2^/g)*R* ~Pb-136.5~ (mm)M10.1951.6590.0851.2740.086M20.2441.7680.1281.3520.130M30.2301.7550.1201.3400.121M40.2361.7240.1211.3160.122G10.1341.1640.0460.9050.048G20.1781.4350.0761.1020.077G30.1761.4740.0771.1270.078G40.1741.3750.0711.0520.072EP0.1621.6060.0681.2060.068Z0.1721.5550.0801.1740.079

The X-ray excitation spectra for the four rubber shields containing Bi at practically the same concentration as the other metal additives (0.30--0.35 mass fraction), Bi+W (0.176 W mass), Bi+W+Gd (0.160 and 0.080 mass fractions of W and Gd, respectively) and Bi+W+Gd+Sb (0.154, 0.077 and 0.031 mass fractions of W, Gd and Sb, respectively) are presented in Fig. [2](#Fig2){ref-type="fig"}. As shown in the figure, the X-ray photon intensities of 74.8, 77.1, 87.3 and 89.9 keV are observed for shield containing Bi only \[[@CR25]\]. Additionally two energy lines that do not originate from Bi excitation, 72.8 and 84.7 keV \[[@CR25]\], are also observed and should be assigned to Pb excitation, which is present despite strong shielding by the detector housing. A natural explanation for this fact is that lead housing excitation can arise from cosmic radiation as confirmed during the background measurements and the partial excitation of lead via the Co-57 γ photons, which although strong attenuated, were not fully absorbed by the shield. After analysis of the recorded spectra, one can conclude, that although much weaker than the photon intensity of the Co-57 source, the secondary X-ray fluorescence radiation arising from the protective shield, should be considered as a dose contributor to the irradiated tissue. The dose aspect and the quality of the registered CT scans suffer because of the additional induced X-ray fluorescence radiation. The addition of a second metallic component with a lower atomic number Z could absorb the Bi X-ray fluorescence photons. For this purpose, the addition of tungsten was examined. The presence of tungsten in the elastomeric bismuth shield leads to a substantial reduction of the all Bi line intensities as evidenced by the presented spectra. However, as a result, four new W photon emission lines are generated in the lower portion of the spectrum with energies characteristic of W excitation, 58.0, 59.3, 67.2 and 69.1 keV (M2 composite) \[[@CR25]\]. These photons can be absorbed by the addition of another additive with a lower Z and X-ray excitation levels slightly below the energy of tungsten-emitted photons, for example, gadolinium. The addition of this element results in a reduction in the W emission intensity; however, two group of photons of 42.7 and 48.7 keV energy, corresponding to gadolinium emissions (M3) \[[@CR25]\], are generated with lower intensities. These photons can be absorbed more easily than those emitted by Bi or W with energies of approximately 60--90 keV. A similar effect of reduced Gd X-ray emission photons could be expected after the addition of Sb (composite M4); however, as shown in Fig. [2](#Fig2){ref-type="fig"}, this result is not clear. From the other side, the low-energy Gd X-ray emission is not as important as the Bi and W fluorescence radiation emission together with the 120--140 keV Co-57 γ radiation. More detailed observations can be seen in Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"} in which the data collected for particular photon emission intensities for Bi, W and Gd are presented for each composite. Given that the lower limit of photon energy visible to our REGe detector is \~40 keV, no γ-ray or X-ray photons below this value were observed, which is of concern to the Sb emission. This fact renders the measurement of photon emissions below 40 keV for Bi, W and Gd impossible. However, due to strong absorption of photons from this energy range and the reduced fluorescence yields for the excitation from shells other than K, the contributions photons at energies below 40 keV could, in practice, be neglected from the total doses outside the shields.Fig. 2Influence of metallic additives (*x* ~Me~) on X-ray emission spectra of the elastomeric shieldsFig. 3(**a**) Influence of the shield thickness on the intensities of the two different Bi concentrations (89.9 and 77.1 keV lines); (**b**) Effect of the shield thickness on the intensity of two W emission lines (for 58.0 and 59.3 keV photons) for composites containing GdFig. 4Comparison of the main X-ray emission lines intensities of Bi **(a)**, and W (**b**) for chosen composite shields

The intensity of the X-ray fluorescence radiation generated by the interaction of the photons with matter depends on the many factors \[[@CR26]\]. This interaction is governed by the following variables: interacting photon flux (*R*~γ~), the probability of the photoelectric absorption (*τ*), the photon emission probability or fluorescence yield (*ω*) for a particular absorption process (K, L1, L2, L3, etc.), the branching ratio for a specific transition of electron de-excitation process (KL2, KL3, KM2, etc.), the concentration of the element being excited (*c*~Me~) and finally, the thickness of the irradiated material (*x*). Additionally, X-ray excitation radiation will be absorbed within the material (*μ*~f~). In general, when more than one group of photons can interact with the irradiated material, the intensity *R*~f~ (photons/s) of the characteristic X-rays generated at distance dx within the shield by the γ ray excitation source is given by Eq. [2](#Equ2){ref-type=""}.$$\documentclass[12pt]{minimal}
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In our experiments, the Co-57 source emits two γ photons at slightly distinct energies. Thus, Eq. [2](#Equ2){ref-type=""} will be transformed to Eq. [3](#Equ3){ref-type=""}.$$\documentclass[12pt]{minimal}
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                \begin{document}$$ R_{{{{\upgamma}}2}}^{ 0} $$\end{document}$ equal the initial intensities of the excitation photons from the Co-57 source at 122.1 and 136.5 keV, respectively; *τ*~1~ and *τ*~2~ represent the photoelectric absorption coefficients for a given photon energy and metal additive; *μ*~1~*, μ*~2~*and μ*~f~ are the mass attenuation coefficients for 122.1, 136.5 keV and the secondary fluorescence radiation, respectively, in cm^2^/g; *ω* and *B* represent the K fluorescence yield and branching ratio for the transition of a specific X-ray emission photon energy; *c*~Me~ is the concentration of the metal additive in the bulk material; and d*x* represents the shield surface density increment in g/cm^2^.

After integrating Eq. [3](#Equ3){ref-type=""} for the initial condition of *R*~f~ = 0 for *x* = 0, one can obtain the following solution for the intensity *R*~f~ of any particular characteristic X-ray photon generated in a shield of thickness *x* (eq. [4](#Equ4){ref-type=""}):$$\documentclass[12pt]{minimal}
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Under these experimental conditions, the observed intensity in the fluorescence radiation is primarily dependent on the first segment of this two-component relationship, while the second component only partially contributes to the total X-ray photon intensity. This conclusion can be easily justified by the contribution of the 136.5 keV radiation flux as compared with that of the main line, which is 122.1 keV (10.7 % emission probability towards 85.6 %). The attenuation factor for the higher energy photons is slightly reduced in the given material, which in fact increases the second component, and does not essentially affect this proportion. This relationship can lead to a saturation curve or a curve with a maximum of fluorescent radiation intensity whose position depends on the physical parameters of the system, particularly the attenuation coefficients. Obviously, these attenuation coefficients, *μ*, are strongly dependent on the effective atomic number of the shield \[[@CR27]\], as is the function of the heavy metal content. In contrast, an increase in the concentration of heavy metals results in a higher probability of photon-Bi atomic interactions. The influence of the rubber shield surface density *x* on the intensity *R*~f~ on the 89.9 and 77.1 keV characteristic Bi lines is shown for the two rubber composites; those containing the different Bi concentrations M1 and G1 are presented in Fig. [3](#Fig3){ref-type="fig"}a.

Figure [3](#Fig3){ref-type="fig"}a clearly shows that the saturation intensity of these two Bi lines is observed for a thickness of approximately 0.7--0.8 g/cm^2^. Increasing the Bi concentration only slightly influences the 89.9 keV line intensity, whereas the 77.1 keV line intensity is affected to a higher extent. This line (77.1 keV) may cause undesirable effects on the quality of the CT scans, thus its intensity should be reduced not only by increasing the thickness of the shields but also by adding another metal capable of absorbing these photons in the range of 72--79 keV. Tungsten, for example, exhibits a high attenuation coefficient in the range of 69--80 keV \[[@CR21], [@CR22]\]. The addition of tungsten---for which the K absorption edge (69.5 keV) \[[@CR25]\] is just below the Bi emission energies---is especially beneficial due to the corresponding energy values for Bi emission and W absorption. However, when these two metals are the only additives, the undesirable effects of the tungsten emissions can be observed in the 58--60 keV energy range, which is still important to the CT protocols. As previously mentioned, the intensities can be further reduced by the addition of another metallic compound with a lower atomic number, *Z*, for example, Gd. In such systems, the reduction in photon emission intensity for all spectral energies from 58 to 90 keV is clearly observed and presented in Fig. [2](#Fig2){ref-type="fig"}. In the presence of the Gd, photons emitted from the W atoms are absorbed more efficiently by shields that have a total thickness greater than 0.5 g/cm^2^. The emission saturation maxima of these W photons are shifted toward lower thickness values comparing with those for Bi (Fig. [3](#Fig3){ref-type="fig"}b).

The question remains as to the measurable effects of the addition of heavy metals in the order of Bi, W, Gd and Sb, and how these additives and their concentrations influence the dose absorbed in the tissue. A suitable parameter for describing the protective shield should provide information regarding the ability of this material to reduce the dose. In a simple approach, the dose rate can be calculated as the sum of the products of the radiation flux (*I*, in 1/cm^2^ s), the mass attenuation coefficient for the material being irradiated (tissue, *μ*~TS~ in cm^2^/g) and the energy of the absorbed photon(s) (*E* in keV) with *k* as an unit correction factor. This dependence can be summarised by Eq. [5](#Equ5){ref-type=""} as follows:$$\documentclass[12pt]{minimal}
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Using the above formula, a dose rate can be estimated for cases both with and without application of an elastomeric shielding material.

The dose reduction factor (DRF) coefficient can be used to assess the shielding properties of the elastomeric composites. The DRF coefficient can be defined simply as a ratio of the dose absorbed after the application of an elastomeric shield (*D*) to that without the application of a shielding material (*D*~o~). The DRF factor can be expressed as follows:$$\documentclass[12pt]{minimal}
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The values of the DRF coefficients for the investigated composites, calculated according to Eq. [6](#Equ6){ref-type=""}, are listed in Table [4](#Tab4){ref-type="table"}. The DRF coefficients for Co-57 radiation are presented with the DRF values calculated including both Co-57 and X-ray fluorescence radiation for comparison. As shown, these values are similar regardless of the method of calculation, with or without considering any X-ray fluoresce radiation induced within the shield material. Differences in the dose reduction factor values are at most 1--2 % for a 1 mm thick layer. Nevertheless, our results clearly indicate that X-ray fluorescence should be taken into account when estimating the total dose reduction for a particular shielding material containing heavy metal additives.Table 4Calculated dose reduction factors (DRF) for examined compositesCompositeAdditive(s)*d* (g/cm^2^) (1 layer)DRF^a^DRF^b^*d* (g/cm^2^) (2 layers)DRF^a^DRF^b^M1Bi0.1950.790.780.3910.610.60M2Bi + W0.2440.720.700.4880.500.49M3Bi + W + Gd0.2300.730.720.4600.510.50M4Bi + W + Gd + Sb0.2360.730.720.4720.520.51G1Bi0.1340.890.880.2670.780.77G2Bi + W0.1780.820.810.3550.670.66G3Bi + W + Gd0.1760.820.810.3520.660.65G4Bi + W + Gd + Sb0.1740.800.800.3490.650.64EPBi + W + Gd0.1620.790.780.3220.620.61ZBi0.1720.780.770.3440.610.60^a^X-ray fluorescence radiation of Bi, W and Gd involved^b^Only for 122.1 and 136.5 keV Co^57^ photons

Conclusions {#Sec4}
===========

Common methods used for determining the shielding properties of materials used in CT examinations require the application of devices such as TLD dosimeters or ionisation chambers and body phantoms to simulate the conditions of human-body CT examinations. Our method is based solely on simple X-ray spectrometric measurements including the fluorescence radiation generated in the shields. Results of our investigations revealed, that fluorescence radiation from the metal additives present in the elastomeric shields have slight contribution to the dose reduction during CT examination. However, the fluorescence radiation in the range of 58--90 keV emitted from two frequently used metal additives, Bi and W, can influence the quality of CT scans. Therefore, the addition of the third metal component, Gd, can substantially shift this radiation to the range of 40 keV, which is less critical for this diagnostic procedure. Another option involves the addition of a fourth metal additive, Sb, to the elastomer shield to decrease the dose. Among the shielding materials examined, the elastomers most able to reduce the radiation dose are those that contain at least three heavy metal additives in concentrations that gradually decrease in the order of Bi, W, Gd and Sb (composites M2--M4).
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